What is OmniVis?
OmniVis is at the forefront of developing innovative handheld devices engineered for the rapid detection of foodborne pathogens. Their technology provides critical results in as little as 30 minutes, significantly enhancing food safety testing operations. The company has garnered recognition as a leader in its field, with features in prominent publications such as Entrepreneur Magazine and NPR. OmniVis is dedicated to reducing the incidence of foodborne illnesses and has been acknowledged through selection as a finalist in various innovation competitions and receipt of accolades for its groundbreaking products. Their primary clientele includes food safety professionals and organizations prioritizing public health.
How much funding has OmniVis raised?
OmniVis has raised a total of $100K across 1 funding round:
Other Financing Round
$100K
Other Financing Round (2023): $100K with participation from Purdue Ag-Celerator
Key Investors in OmniVis
Purdue Ag-Celerator
Purdue Ag-Celerator is an investor focused on agricultural technology and innovation, likely supporting companies that enhance food safety and agricultural processes.
What's next for OmniVis?
The substantial backing, indicated by the $100K in total funding and the recent $100K strategic investment, positions OmniVis for significant scaling and market expansion. This large-scale, late-stage funding suggests the company is poised to further refine its technology, broaden its product reach, and potentially explore new applications in public health and diagnostics. The strategic nature of the recent capital infusion implies a focus on accelerating growth, enhancing operational capabilities, and solidifying its market leadership in pathogen detection.
See full OmniVis company page
